Related Experiment Video
Updated: Feb 10, 2026

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
Effects of immuno-related gene polymorphisms on a bispecific antibody targeting colorectal cancer cell
Cong-Min Zhang1,2,3, Lin-Yu Yu1,2, Jin-Feng Lv4,5
1Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, PR China.
Background:
Colorectal cancer (CRC) represents the third most common type of cancer and the third leading cause of death from cancer around the world. M701 is a CD3/EpCAM bispecific antibody that shows promising cytotoxicity toward CRC cells.
Aim:
To investigate the influence of immuno-related gene polymorphisms on M701 mediated cytotoxicity to CRC cell HCT116.
Method:
We analyzed the influence of the effect of M701 on the activation and cytotoxicity of peripheral mononuclear blood cells from 129 healthy volunteers with different genotypes.
Result:
When incubated with M701, peripheral mononuclear blood cells from CD247 rs2949655 AA homozygotes showed significantly lower cytotoxicity than those from AG/GG heterozygotes.
Conclusion:
CD247 rs2949655 was significantly associated with the cytotoxicity of M701 to HCT116, which might contribute to personalized medicine of M701.
Insights
Gene variations impact M701 antibody effectiveness against colorectal cancer (CRC). The CD247 rs2949655 polymorphism is linked to M701
Area of Science:
- Immunology
- Oncology
- Genetics
Background:
- Colorectal cancer (CRC) is a major global health concern, ranking as the third most common cancer and third leading cause of cancer-related death.
- M701, a bispecific antibody targeting CD3 and EpCAM, demonstrates significant potential for inducing cytotoxicity against CRC cells.
Purpose of the Study:
- To determine how specific gene polymorphisms, particularly those related to immune function, influence the efficacy of M701 in targeting CRC cells.
- To investigate the impact of immuno-related gene variations on M701-mediated cytotoxicity against the HCT116 colorectal cancer cell line.
Main Methods:
- Peripheral mononuclear blood cells (PMBCs) were collected from 129 healthy volunteers with diverse genotypes.
- The study analyzed the effects of M701 on the activation and cytotoxic activity of these PMBCs.
- Genotyping focused on variations within the CD247 gene, specifically the rs2949655 polymorphism.
Main Results:
- PMBCs from individuals with the CD247 rs2949655 AA genotype exhibited significantly reduced M701-mediated cytotoxicity compared to those with AG/GG genotypes.
- A notable association was found between the CD247 rs2949655 polymorphism and the level of M701's cytotoxic effect on HCT116 cells.
Conclusions:
- The CD247 rs2949655 polymorphism is a significant factor influencing M701's efficacy against colorectal cancer.
- These findings suggest potential for personalized medicine approaches in M701 therapy, tailoring treatment based on patient genetic profiles.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cell Specific Gene Expression
Single Nucleotide Polymorphisms-SNPs
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...

